ArticleVaccines2022

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults.

Hironori Nakagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.